2009
DOI: 10.1258/om.2009.090027
|View full text |Cite
|
Sign up to set email alerts
|

Diabetes insipidus in pregnancy

Abstract: Diabetes insipidus is an uncommon condition with various aetiologies. Recent research has uncovered new mechanisms underlying the syndrome. Careful attention to management is essential in pregnant women to avoid serious complications. Diabetes insipidus in pregnancy may be due to relative reduction in secretion of AVP from the posterior pituitary (cranial DI), increase in breakdown of AVP by placental cystine aminopeptidase with vasopressinase activity, or resistance of the rental tubules to AVP (nephrogenic D… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
5
0
1

Year Published

2011
2011
2021
2021

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 12 publications
(6 citation statements)
references
References 19 publications
0
5
0
1
Order By: Relevance
“…The first is central diabetes insipidus as a consequence of failed anti-diuretic hormone secretion due to posterior pituitary infarction. 3,4 This presents with thirst and polyuria with normal serum sodium; if water intake falls behind urinary excretion then sodium levels rise with dehydration. The second is disruption of the hypothalamic thirst centres following an ischaemic insult although no significant hyponatraemia was seen in the study.…”
Section: Discussionmentioning
confidence: 99%
“…The first is central diabetes insipidus as a consequence of failed anti-diuretic hormone secretion due to posterior pituitary infarction. 3,4 This presents with thirst and polyuria with normal serum sodium; if water intake falls behind urinary excretion then sodium levels rise with dehydration. The second is disruption of the hypothalamic thirst centres following an ischaemic insult although no significant hyponatraemia was seen in the study.…”
Section: Discussionmentioning
confidence: 99%
“…A partial explanation would be the transient reduction of the uterine artery flow and of systolic velocity after the administration of short-acting Octreotide [ 120 ]. Pegvisomant (category B—FDA) has proven to be a safe and effective drug; fetal concentration is minimal suggesting a low or absent transplacenta passage [ 120 , 121 ]. Although medical treatment of pregnant women with acromegaly is not associated with major side effects of the mother or fetus, it should be discontinued during pregnancy.…”
Section: The Endocrine Disorders and Pregnancymentioning
confidence: 99%
“…Diabetes insipidus (DI) is a rare disorder characterized by antidiuretic hormone (ADH) deficiency. Produced in the hypothalamus and stored in the posterior pituitary, ADH acts directly on the distal tubules to allow water reabsorption in response to dehydration [ 121 ]. DI can be a result of ADH hyposecretion in the posterior pituitary gland (central DI, endocrine) or lack of response to its action in the kidney (nephrogenic DI, peripheral) [ 121 ].…”
Section: The Endocrine Disorders and Pregnancymentioning
confidence: 99%
See 1 more Smart Citation
“…Zu den Symptomen gehören hypotonische Polyurie, Polydipsie, Müdigkeit, Gewichtsverlust, verminderter Hautturgor und Übelkeit, die sich in der Regel über ein paar Tage entwickeln und dann verschlimmern können, wenn diese Erkrankung nicht richtig erkannt und behandelt wird [5,6].…”
Section: Diskussionunclassified